指南与共识消化道肿瘤与早癌消化内镜

ACG临床指南:腺瘤性结直肠息肉病综合征的诊断与管理

ACG Clinical Guideline: Diagnosis and Management of Adenomatous Colorectal Polyposis Syndromes.
指南 / 共识 · Am J Gastroenterol · 2026-01-01

该指南由美国胃肠病学会(ACG)采用GRADE方法制定,针对遗传性腺瘤性结直肠息肉病综合征,提供风险评估人群选择、胚系基因检测时机与方式、内镜与手术干预降低癌症风险及化学预防的临床指导,并重点阐述家族性腺瘤性息肉病与MUTYH相关息肉病的管理更新。

要点

  • 通过个人史与家族史风险评估及胚系基因检测识别遗传性腺瘤性息肉病综合征。
  • 及时的内镜与手术管理可降低结直肠及肠外癌症发病率和死亡率。
  • 指南更新了息肉病与癌症风险降低策略的管理推荐。

核心结论

  • 通过风险评估和胚系基因检测识别遗传性腺瘤性息肉病综合征,并实施及时的内镜与手术管理,可降低癌症发病率和死亡率。

研究设计与样本

  • 美国胃肠病学会(ACG)采用GRADE方法制定的临床指南。

主要发现

  • 遗传性腺瘤性结直肠息肉病综合征在遗传方式、发病年龄、表型表达和癌症风险上存在差异。
  • 最常见的癌症风险涉及胃肠道,包括结肠、直肠、十二指肠、壶腹和胃。

关键数值与推荐

  • 指南推荐对具有表型结直肠息肉病的患者进行基因检测,并对已知家族性胚系致病性变异或临床特征提示遗传性腺瘤性息肉病的家庭进行症状前诊断。
  • 指南根据基因检测结果或未进行基因检测的情况提供管理策略。

临床怎么用

  • 临床应通过个人史和家族史风险评估识别需进行遗传性腺瘤性息肉病综合征风险评估的个体。
  • 根据基因检测结果或未检测情况,选择内镜和手术干预以降低癌症风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The hereditary adenomatous colorectal polyposis syndromes are incurable, systemic, cancer risk predisposition syndromes with substantial morbidity and mortality. They differ in their mode of inheritance, age at disease onset, phenotypic expression, and cancer risk. The most common cancer risks involve the gastrointestinal tract including the colon, rectum, duodenum, ampulla, and stomach. Identifying these syndromes through personal and family history risk assessment and germline genetic testing, along with timely surgical and endoscopic management, can reduce cancer incidence and mortality. These guidelines use the Grading of Recommendations, Assessment, Development, and Evaluation methodology to provide clinical guidance on the selection of individuals who should undergo a risk assessment for a hereditary adenomatous colorectal polyposis syndrome, modality and timing of germline genetic testing, cancer risk mitigation through endoscopic and surgical interventions, and the role of chemoprevention. This document reviews the approach to genetic testing in patients with phenotypic colorectal polyposis and the impact of presymptomatic diagnosis in families with a known familial germline pathogenic variant or clinical features suggestive of a hereditary adenomatous polyposis syndrome. Management strategies for patients based on genetic test results or without genetic testing are provided. We also review colorectal and extracolonic phenotypic benign and malignant manifestations of the known hereditary syndromes with a focus on the 2 most common hereditary colorectal polyposis syndromes: familial adenomatous polyposis and MUTYH-associated polyposis. The document concludes with recommendations on polyposis and cancer risk mitigation strategies and highlights updates to management since the previous guideline was published.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Mankaney G, Idos GE, Stoffel EM, et al. ACG Clinical Guideline: Diagnosis and Management of Adenomatous Colorectal Polyposis Syndromes. Am J Gastroenterol. 2026. PMID: 42683623. doi:10.14309/ajg.0000000000004105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。